Therapeutic insights in clonal evolution of MPN to accelerated or blastic phase

1 Views
administrator
administrator
07/29/23

In this presentation from the 2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Raajit K. Rampal discusses therapeutic insights in the clonal evolution of myeloproliferative neoplasms (MPNS) to accelerated or blastic phase.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Spec....ialty-Search.aspx?se

© 2017 Imedex, LLC.

Show more
0 Comments Sort By

    No comments found

    Facebook Comments

    Up next

    Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
    00:46:23
    Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
    administrator
    3 Views
    Expert Insights – Cervical Cancer Awareness Month
    00:01:38
    Expert Insights – Cervical Cancer Awareness Month
    administrator
    0 Views
    Insights into the treatment of peripheral T-cell lymphomas and the role of autologous transplant
    00:01:15
    Insights into the treatment of peripheral T-cell lymphomas and the role of autologous transplant
    administrator
    3 Views
    Clonal evolution in patients with CTCL
    00:02:24
    Clonal evolution in patients with CTCL
    administrator
    3 Views
    The evolution of CTCL treatment
    00:01:45
    The evolution of CTCL treatment
    administrator
    1 Views
    Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
    00:06:43
    Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
    administrator
    4 Views
    Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
    00:02:44
    Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
    administrator
    4 Views
    The Genetics of Melanoma: Searching for New Therapeutic Targets - Yardena Samuels
    00:25:48
    The Genetics of Melanoma: Searching for New Therapeutic Targets - Yardena Samuels
    administrator
    3 Views
    BAP1: Insights and New Understandings - A/Prof Sarah Kummerfeld
    00:11:03
    BAP1: Insights and New Understandings - A/Prof Sarah Kummerfeld
    administrator
    3 Views
    New insights into the myeloproliferative neoplasms
    01:01:04
    New insights into the myeloproliferative neoplasms
    administrator
    4 Views
    Key Insights: Leukemia & Myeloid Disorders
    00:07:18
    Key Insights: Leukemia & Myeloid Disorders
    administrator
    1 Views
    CRUSH!!MDS - A phase 2 study of SGI-110 in Philadelphia-negative myeloproliferative neoplasms
    00:05:27
    CRUSH!!MDS - A phase 2 study of SGI-110 in Philadelphia-negative myeloproliferative neoplasms
    administrator
    1 Views
    Key Insights: Myeloproliferative Neoplasms and Myelodysplastic Syndromes
    00:22:08
    Key Insights: Myeloproliferative Neoplasms and Myelodysplastic Syndromes
    administrator
    4 Views
    The need for novel therapeutic agents in myeloproliferative neoplasms
    00:01:33
    The need for novel therapeutic agents in myeloproliferative neoplasms
    administrator
    3 Views
    11/01/22 Eosinophils as Mediators of Rheumatological Disease and as Therapeutic Targets
    01:04:03
    11/01/22 Eosinophils as Mediators of Rheumatological Disease and as Therapeutic Targets
    administrator
    0 Views
    Pursue 17 A (Live): Classification and Clinical Manifestations of the Clonal Myeloid Disorders
    01:15:46
    Pursue 17 A (Live): Classification and Clinical Manifestations of the Clonal Myeloid Disorders
    administrator
    2 Views
    Pursue 17 A (Uploaded): Classification and Clinical Manifestations of the Clonal Myeloid Disorders
    01:10:31
    Pursue 17 A (Uploaded): Classification and Clinical Manifestations of the Clonal Myeloid Disorders
    administrator
    2 Views
    252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting
    02:53:28
    252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting
    administrator
    2 Views
    Phase 2b Trial Results Comparing Aldoxorubicin vs. Doxorubicin in Soft Tissue Sarcoma Patients
    00:13:21
    Phase 2b Trial Results Comparing Aldoxorubicin vs. Doxorubicin in Soft Tissue Sarcoma Patients
    administrator
    3 Views